This webinar will likely be hosted reside and out there on-demand
Monday, December sixteenth, 2024
12:30 – 2:00 PM ET
Focused therapies are reworking the medical area by enabling clinicians to exactly and successfully deal with sufferers with severe ailments. Nonetheless, many proteins, comparable to these labeled as transcription elements, small GTPases, and phosphatases, have issue interacting with drug compounds. In consequence, scientists think about these targets undruggable.
On this webinar delivered to you by The Scientist, Andrew Tsourkas and Chris Parker will talk about how they’re turning the phrase “undruggable” on its head by using new approaches to focus on undruggable proteins concerned in most cancers, autoimmune ailments, and past.
Matters to be lined
- Engineering a system to ship antibodies and different protein-based concentrating on ligands into the cytosol to inhibit and degrade cancer-associated proteins
- Growing photoaffinity-based chemical proteomic methods to establish small molecule binding websites on proteins and utilizing this data to design chemical probes in opposition to disease-relevant targets
 |
Andrew Tsourkas, PhD |
 |
Chris Parker, PhD |
